Univerzita Tomáše Bati ve Zlíně

---

Životopis

Vzdělání

Education

1992    School leaving examination at the secondary grammar school in the town of Strážnice

1998    MD (MUDr.) General medicine degree at the Medical faculty of Palacký University in Olomouc

2014    PhD degree at Charles University in Prague, The thesis: Laboratory diagnostics of kidney function,

 

Postgraduate specialization

• Clinical Biochemistry
• Internal Medicine
• Clinical Pharmacology
• Cerebrospinal fluid cytology
• 2016 Registration as European Specialist in Laboratory Medicine (EuSpLM)

• 2002    State examination of the English language
• 2004    Specialisation in Internal Medicine, The Licence of the Czech Medical Chamber for Internal Medicine
• 2005    Specialisation in Clinical Biochemistry (board examination IPVZ Prague)
• 2006 – 2008   Member of the Quality Board of the Uherské Hradiště hospital
• 2007    The Licence of the Czech Medical Chamber for Consultant of Clinical Biochemistry
• 2008    Appointment as Consultant of Clinical biochemistry for the Zlín region (appointed by the Czech Society of Clinical Biochemistry)
• 2008    Examination of Cytology of cerebrospinal fluid (board examination IPVZ Prague)
• 2009    Appointment as Consultant of Clinical Biochemistry for the district of Zlín: appointed by The Council of the Zlín region
• 2013    Completed a 1-year course in Management and Economy in the health care system
• 2014    PhD degree at the Medical Faculty of Charles University in Hradec Králové, the thesis: Laboratory diagnostics of kidney function, Supervisor: Prof. Vladimir Palička, MD, PhD, Dr. h.c.

• 2015    specialization in Clinical Pharmacology (board examination IPVZ Prague)
• 2025 Preparation to defend Habilitation (Associate Professor) thesis entitled Indication and interpretation of laboratory test results 

 

Stáže a studijní pobyty

• April 23^rd – 26^th 2012, University of Birmingham, Renal Institute
  October 12th – 19^th, 2013, University of Wolverhampton

• November 12th ^– 19^th, 2016, University of Florence
• March 18^th  – 23^rd, Medical University in Wroclaw
• February 18^th  – 23^rd 2019, University of Zaragoza  

Průběh zaměstnání

• 1^st February 1998 – 31^st December 2007       Uherské Hradiště hospital, department of internal medicine and department of clinical biochemistry
  2004 – 2007   Deputy head at the Department of Clinical Biochemistry
• Since January 2008 Head of the Department of Clinical Biochemistry and Pharmacology, Tomas Bata Hospital in Zlín, The Czech Republic
• Assistant Professor of Clinical Biochemistry at Charles University in Prague (Since 2016)
• Assistant Professor of Clinical Biochemistry at the Medical faculty of the University of Ostrava (Since 2014)
• Assistant Professor of Clinical Biochemistry at Tomas Bata University in Zlín (Since 2025)

Členství v organizacích

• European Federation of Clinical Chemistry and Laboratory Medicine,
  Committee Postanalytical Phase (Full member, since 2020),
  Committee Preanalytical Phase (Corresponding member, since 2024),
  Committee Clinical and Analytical Performance Specifications (Corresponding member, since 2017),

• European Atherosclerosis Society
• Czech Medical Chamber (CMC), Head of Clinical biochemistry committee of Scientific Board of CMC, Head since 2017
• Czech Society of Clinical Biochemistry, Consultant of Clinical biochemistry for the Zlín region, since 2008
• Czech myeloma working group
• Community of physicians of regions of Zlin, Uherské Hradiště, Vsetín, Kroměříž, Scientific secretary
• Czech Society for Atherosclerosis
• Czech society of Clinical pharmacology
• Accreditation committee of the Ministry of Health

 

Členství v orgánech

Tomas Bata Hospital Zlín, Scientific Board

• Ethics Committee of Tomas Bata Hospital, Member, since 2012

---

Tvůrčí činnost

Publikace

Výstupy z projektů

Další publikace

Celkem recenzovaných publikací: 68

Publikace s IF: 42

Original papers: 42 Guidelines: 3 Reviews: 7 Case studies: 13 Opinion papers 3

ORCID https://orcid.org/0000-0002-8392-5003

1. Šálek T, Musil P, Zlatníková I. What is uric acid concentration in urine in patients with uric acid kidney stones? – a case study. Biochem Med (Zagreb). 2025;35:031001 IF 1,800
2. Šálek T, Klhůfek J, Vodička M, Pšenčík M. Cystatin C for gentamicin dosing – a case study. Biochem Med (Zagreb). 2025;35:030902 IF 1,800
3. Klhůfek J, Vodička M, Ponížil P, Ryšavý I, Fojtík P, Kojecký V, Šálek T. Thiazide-Associated Hyponatremia: A Retrospective Cohort Study Comparing Hydrochlorothiazide Versus Indapamide Versus Chlorthalidone. J Clin Hypertens (Greenwich). 2025 May;27(5):e70060. doi: 10.1111/jch.70060. PMID: 40346873.
   IF 2,7 (corresponding author)
4. European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC). Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study. Lancet Diabetes Endocrinol. 2024 Nov;12(11):811-823. doi: 10.1016/S2213-8587(24)00221-3. Epub 2024 Oct 4. PMID: 39374602. IF 44
5. Šálek Tomáš, Musil, Pavel, Vermeersch, Pieter, Marrington, Rachel, Dikmen, Zeliha G., Poláchová, Radka, Kipman, Ulrike, Kouri, Timo T., Cadamuro, Janne and on behalf of the Working Group Preanalytical Phase (WG-PRE) and Task and Finish Group Urinalysis (TFG-U), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM),. “Preservation of urine specimens for metabolic evaluation of recurrent urinary stone formers” Clinical Chemistry and Laboratory Medicine (CCLM), vol. 63, no. 1, 2025, pp. 129-138. https://doi.org/10.1515/cclm-2024-0773 IF 3,800
6. Šálek T, Stejskal D. Pseudonormokalemia case report – What does it mean to have normal blood potassium? Biochem Med (Zagreb). 2024;34:021002 IF 3,800
7. Cornes M, Vermeersch P, Šimundić A, Von Meyer A, Šálek T, Meyer B, Costelloe S, De Guire V, Gomez-Rioja R, Cadamuro J. The final part of the CRESS trilogy – how to evaluate the quality of stability studies. Clinical Chemistry and Laboratory Medicine (CCLM). 2024. https://doi.org/10.1515/cclm-2024-0527 IF 3,800
8. Šálek T. Calcium Kidney Stone Patient with Normocalcemia. J Appl Lab Med. 2024 May 2;9(3):641-644 IF 1.800
9. Šálek T, Soška V, Budina M, Vecka M, Šálková V, Vrablík M. Reporting LDL cholesterol results by clinical biochemistry laboratories in Czechia and Slovakia to improve the detection rate of familial hypercholesterolemia. Biochem Med (Zagreb). 2023;33:030705. IF 3,800
10. Cadamuro J, Winzer J, Perkhofer L, von Meyer A, Bauça JM, Plekhanova O, Linko-Parvinen A, Watine J, Kniewallner KM, Keppel MH, Šálek T, Mrazek C, Felder TK, Oberkofler H, Haschke-Becher E, Vermeersch P, Kristoffersen AH, Eisl C. Efficiency, efficacy and subjective user satisfaction of alternative laboratory report formats. An investigation on behalf of the Working Group for Postanalytical Phase (WG-POST), of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clin Chem Lab Med. 2022 Jun 14. doi: 10.1515/cclm-2022-0269. Epub ahead of print. PMID: 35696446. IF 8,490
11. Cadamuro J, Decho C, Frans G, Auer S, von Meyer A, Kniewallner KM, Drerup M, Heinrich E, Keppel MH, Mrazek C, Felder TK, Oberkofler H, Haschke-Becher E, Kipman U, Salek T, Vermeersh P; European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group “Preanalytical Phase” (WG-PRE). Acidification of 24-hour urine in urolithiasis risk testing: An obsolete relic? Clin Chim Acta. 2022 Jul 1;532:1-9. doi: 10.1016/j.cca.2022.05.010. Epub 2022 May 19. PMID: 35597305. IF 6,314
12. Šálek T, Musil P, Pšenčík M, Palička V. Post-collection acidification of spot urine sample is not needed before measurement of electrolytes. Biochem Med (Zagreb). 2022;32:020702 IF 3,300
13. Klhůfek J, Šálek T. Thiazide-associated hyponatremia in internal medicine patients: analysis of epidemiological and biochemical profiles. Postgrad Med. 2022 Jun;134(5):487-493. IF 3,84 (corresponding author)
14. Šálek T. Pseudohyponatremia and falsely increased serum osmolal gap caused by paraprotein in a patient with severe metabolic acidosis – a case study. Rev Romana Med Lab. 2021;29(2):229–33. IF 1,027
15. Šálek, T. Extreme diet without kalcium may lead to hyperoxaluria and kidney stone recurrence – a case study. J Clin Lab Anal.2020;00:e23512 IF 1,54
16. Salek T, Schneiderka P, Studená B, Votroubková M. Survey on request form content and result reporting in therapeutic drug monitoring service among laboratories in Czechia and Slovakia. Biochem Med (Zagreb) 2020; 30:020706 IF 2,202
17. Vodička M, Slanař O, Pisár M, Šálek T. Rosuvastatin-induced rhabdomyolysis due to medication errors. Ceska Slov Farm. 2020;69(2):100-102.
18. Šálek, T., Vodička, M. & Gřiva, M. Cystatin C may be better than creatinine for digoxin dosing in older adults with atrial fibrillation. J Clin Lab Anal.2020;00:e23427. https://doi.org/10.1002/jcla.23427, 5- letý IF 2,40
19. Šálek T, Adamíková A, Ponížil P. The fat mass, estimated glomerular filtration rate, and chronic inflammation in type 2 diabetic patients. J Clin Lab Anal.2020;00:e23229. https ://doi.org/10.1002/jcla.23229 . IF 1,54
20. Šálek, T., Vodička, M. & Gabrhelík, T. Estimated glomerular filtration rate in patients overdosed with gentamicin. J Lab Med 2020; 44: 35-39 IF 0,379
21. Šálek T, Friedecký B, Kratochvíla J, Pelinková K, Budina M. Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia. Biochem Med (Zagreb). 2019 Oct 15;29(3):030704. IF 2,2
22. Vyoralová Z a Šálek T., Recidivující infekce močových cest a cystinurie. Urol. praxi, 2019; 20(4): 186-190
23. Šálek, T., & Adamíková, A. (2019). Cystatin C measurement leads to lower metformin dosage in elderly type 2 diabetic patients. Basic & clinical pharmacology & toxicology, 124(3), 298-302. IF 2,5

 

24. Salek T, Dhaifalah I, Langova D, Havalova J. The prevalence of maternal hypothyroidism in first trimester screening from 11 to 14 weeks of gestation. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2019;163 :265-8. IF 1,09
25. Griva M, Stastny J, Kopriva P, Slabak M, Coufal Z, Jarkovsky J, Svoboda M, Salek T et al. Selective coronary angiography, percutaneous coronary intervention and asymptomatic peri-procedural myocardial injury. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019; 163:324-30. IF 1,09
26. Šálek T, Friedecký B, Budina M. Cystatin C–Implementation in clinical laboratory practice. Klin Biochem Metab 2019;: 16-18
27. Šálek T, Kurfürstová I, Pšenčík M. Urolitiáza-efekt terapie indapamidem–kazuistika. Klin Biochem Metab 2018; Apr:183.

 

28. ŠÁLEK, Tomáš. Pseudohyperkalemia-Potassium released from cells due to clotting and centrifugation-a case report. Biochem Med (Zagreb) 2017, 28.1: 1-5. IF 3,65
29. Šálek, T., Dhaifalah, I., Langova, D., & Havalová, J. (2018). Maternal thyroid‐stimulating hormone reference ranges for first trimester screening from 11 to 14 weeks of gestation. J Clin Lab Anal. IF 1,33
30. Kadlčková E, Rohoň P, Fürst T, Červínek L, Jonášová A, Šálek T, Tesař J, Stavařová Y. Verification of Survival Predictors in Elderly Patients with Myelodysplastic Syndrome from Outpatient Clinical Practice. International Journal of Gerontology. 2018 Mar 1;12(1):27-31. IF 0,5
31. Salek, T., Andel, I., & Kurfurstova, I. Topiramate induced metabolic acidosis and kidney stones–a case study. Biochem Med (Zagreb) 2017; 27(2): 404-410 IF 3,65
32. Dhaifalah I, Salek T, Langova D, Cuckle H. Incorporating thyroid markers in Down syndrome screening protocols. Prenatal diagnosis. 2017 May; 37(5):510-4. IF 2,4
33. Šíma M, Vodička M, Marešová V, Šálek T, Čabala R, Slanař O. Adherence with perindopril therapy: a pilot study using therapeutic drug monitoring of perindoprilat and an evaluation of the clearance estimation. International journal of clinical pharmacy. 2017; 39(5):1095-100. IF 1,9
34. Kurfürstová I, Šálek T, Kadlčková E, Pšenčík M. Analytical Interference Leading to a Diagnosis of Lymphoproliferative Disorder. Klinicka onkologie: casopis Ceske a Slovenske onkologicke spolecnosti. 2017; 30(1):55-7.

 

35. Dhaifalah I, Salek T, Langova D, Cuckle H. Routine first trimester screening for maternal thyroid disease. Journal of Fetal Medicine. 2017 Mar 1; 4(1):19-23.

 

36. Martin J, Buttigieg D, Silhavik J, Flegar-Meštrić Z, Adkins A, Gasljevic V, Šálek T, Horvath A, Borg C, Jakovcic M, Adonics A. Transnational Evaluation of a Continuing Professional Development Activity for Biomedical Scientists Based on the Clinical Laboratory Pre-analytical Phase. American Journal of Laboratory Medicine. 2017; 2(6):126-31.

 

37. Zakharov, S., Pelclova, D., Navratil, T., Belacek, J., Latta, J., Pisar, M., Rulisek, J., Leps, J., Zidek, P., Kucera, C., Bocek, R., Mazur, M., Belik, Z., Chalupa, J., Talafa, V., Kodras, K., Nalos, D., Sedlak, C., Senkyrik, M., Smid, J Salek, T. et al. (2017) Efficiency of acidemia correction on intermittent versus continuous hemodialysis in acute methanol poisoning. Clinical Toxicology 2017; 55:123-132, IF 4,4

 

38. Linzer P, Filip M, Jurek P, Šálek T, Gajdoš M, Jarkovský J. Comparison of biochemical response between the minimally invasive and standard open posterior lumbar interbody fusion. Neurologia i neurochirurgia polska. 2016; 50(1):16-23. IF 0,86

 

39. Zakharov S, Navratil T, Salek T, Kurcova I, Pelclova D. Fluctuations in serum ethanol concentration in the treatment of acute methanol poisoning: a prospective study of 21 patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159(4):666-76. IF 1,661

 

40. Linzer P, Filip M, Šámal F, Kremr J, Šálek T, Gajdoš M, Jarkovský J. Comparison of biochemical markers of muscle damage and inflammatory response between the open discectomy, microsurgical discectomy, and microsurgical discectomy using tubular retractor. Journal of Neurological Surgery Part A: Central European Neurosurgery. 2015; 76:384-91. IF 0,493

 

41. Salek T, Vesely P, Bernatek J. Estimated glomerular filtration rate in oncology patients before cisplatin chemotherapy. Klin Onkol. 2015; 28:273-7.

 

42. Klátil S, Hynčica J, Šálek T. Překvapivý nález cystinové urolitiázy u dospělé ženy. Urol. praxi. 2015; 16: 33-5.
43. Martin, J., Buttigieg, D., Šilhavík, J., Flegar-Meštrić, Z, Adkins, A., Gasljevic, V., Šálek, T. et al. Transnational Evaluation of a New Continuing Professional Development Activity for Biomedical Scientists Based on the International Organisation for Standardisation for Medical Laboratories ISO 15189. American Journal of Educational Research. 2015; 3(5):637-642 IF 2,275
44. Salek T, Humpolicek P, Ponizil P. Metabolic disorders due to methanol poisoning. Biomedical Papers. 2014; 158:635-40. IF 1,661
45. Šálek T., Ponížil P.: Estimated glomerular filtration rate in diabetic patiens Biochem. Metab 2014; 22(43): 4-7.
46. Jabor, A., Franeková, J., Kubíček, Z., Šálek, T.: eGFR a problémy interpretace rovnic CKD-EPI Biochem. Metab 2014; 22(43): 8-10.
47. Zakharov S, Kurcova I, Navratil T, Salek T, Komarc M, Pelclova D. Is the measurement of serum formate concentration useful in the diagnostics of acute methanol poisoning? A prospective study of 38 patients. Basic Clin Pharmacol Toxicol. 2015;116(5):445‐451IF 2,294
48. Zakharov S, Pelclova D, Navratil T, Belacek J, Kurcova I, Komzak O, Salek T, Latta J, Turek R, Bocek R, Kucera C, Hubacek JA, Fenclova Z, Petrik V, Cermak M, Hovda KE. Intermittent hemodialysis is superior to continuous veno-venous hemodialysis/hemodiafiltration to eliminate methanol and formate during treatment for methanol poisoning. Kidney Int. 2014 Jul;86(1):199-207 IF 7,9
49. Šálek T., Palička V. Comparison of creatinine clearance and estimated glomerular filtration rate in patients with chronic kidney disease. Biochem. Metab., 22 (43), 2014, No. 3,
50. Martin, J., Buttigieg, D., Šilhavík, J., Flegar-Meštrić, Z, Adkins, A., Gasljevic, V., Šálek, T. et al. 2014. Enhance It – Enhancing Hospital Laboratory Standards for Continuing Professional Development: Transnational Evaluation of a Novel CPD Activity for Biomedical Scientists. American Journal of Educational Research 2014; 11: 1110–14 IF 2,275
51. Martin, J., Gasljevic, V., Šálek, T., Horvath, A., Borg, C., Flegar-Meštrić, Z., Jakovcic, M., Silhavik, J., Adonics, A., Szlamka, Z., Brincat, I., Buttigieg, D., Ciantar, N., Sciortino, A., Mifsud, A., Adkins, A., Bennett, T., Rice, K., & Taylor, Y. (2015). Comparison of approaches and measurement of continuing professional development for specialists in laboratory medicine within four European countries, Clin Chem Lab Med 2015; 53: 35-44 IF 3,009
52. Šálek T., Macko J., Šafařík P., Pšenčík M. Porovnání dvou nejčastějších metod na stanovení celkového bilirubinu u novorozenců. Biochem. Metab. 2015, 23 (44), No. 1, p. 17-20.
53. Šálek Tomáš, Veselý Pavel, Bernátek Jaromír. Odhadovaná glomerulární filtrace u onkologických pacientů před chemoterapií cisplatinou. Klin Onkol. 2015; 28: 273-277.
54. Šálek T, Macko J, Šafařík P, Pšenčík M. Porovnání dvou nejčastějších metod na stanovení celkového bilirubinu u novorozenců. Biochem. Metab 2015; 23(44): 17-20

 

55. Linzer, P., Filip, M., Jurek, P., Šálek, T., Gajdoš, M., & Jarkovský, J. Comparison of biochemical response between the minimally invasive and standard open posterior lumbar interbody fusion. Neurol Neurochir Pol 2016; 50:16‐ IF 0,747
56. Kurfürstová I, Šálek T, Kadlčková E. Renální insuficience při onemocnění myelomem z lehkých řetězců. Interní Med 2014; 16: 164–166.

 

57. Vodička M, Sálek T, Röderová E, Cerný D. Hepatotoxicity induced by cyproteron acetate in the prostate carcinoma treatment-a case report. Klinicka onkologie: casopis Ceske a Slovenske onkologicke spolecnosti. 2013; 26:47-8.

 

58. Šálek T, Moravčíková D, Humpolíček P, Tichý M, Palička V. The prevalence of decreased glomerular filtration rate in patients with monoclonal gammopathy of undetermined significance. Klin Biochem Metab. 2013; 21: 25-29

 

59. Dufka Antonín a Šálek Tomáš. Recidivující synkopa jako vedoucí symptom u parciálního centrálního diabetes insipidus. Med. Pro Praxi 2007; 4: 369–370

 

Guidelines, Review, Opinion papers

 

1. Zaninotto M, Agnello L, Dukic L, Šálek T, Linko-Parvinen A, Kalaria T, Vermeersch P; European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Committee-Harmonization (C-H) and Committee -Postanalytical Phase (C-POST). Is it feasible for European laboratories to use SI units in reporting results? Clin Chem Lab Med. 2025 Feb 19. doi: 10.1515/cclm-2025-0113. Epub ahead of print. PMID: 39963968. IF 3,800

 

2. Zima T., Racek J., Ryšavá R., Čertíková Chábová V., Zieg J., Tesař V., Viklický O., Friedecký B., Kubíček Z., Kratochvíla J., Rajdl D., Šálek T., Kalousová M. Česká nefrologická společnost a Česká společnost klinické biochemie ČLS JEP Doporučení k diagnostice chronického onemocnění ledvin (odhad glomerulární filtrace a vyšetřování proteinurie) Biochem. Metab. 2021 29(2):94–103.

 

3. Hassanian-Moghaddam, H, Zamani, N, Roberts, D, Brent, J, McMartin, K, Aoron, C, Eddleston, M, Dargon, P, Olson, K, Nelson, L, Bhalla, A, Hanston, P, Jacobsen, D, Megarbane, B, Balali-Mood, M, Buckley, N, Zakharov , S, Paasma, R, Jarwani, B, Mirafzal, A, Salek T, Hovda. Consensus statements on the approach to patients in a methanol poisoning outbreak. Clin Toxicol (Phila) . 2019;57:1129-1136 IF 4,4 
4. Šálek T. Odhadovaná glomerulární filtrace dospělých pacientů. Klinická farmakologie a farmacie. 2016 Jan 1;29(4):153-5.
5. Zima T., Racek J., Tesař V., Viklicky O., Teplan V., Schuck O., Janda J., Friedecky B.,Kubiček Z., Kratochvila J., Rajdl D., Šalek T., Kalousova M., Granatova J Česká nefrologická společnost ČLS JEP a Česká společnost klinické biochemie ČLS JEP. Doporučení k diagnostice chronického onemocnění ledvin (odhad glomerulární filtrace a vyšetřování proteinurie). Biochem. Metab 2014; 22: 138–152.
6. Šálek Tomáš, Janka Franeková, Antonín Jabor a Bedřich Friedecký. Postanalytical phase and interpretation of laboratoř test results (Post-postanalytical phase). Klin. Biochem. Metab 216; 24: 82–87.
7. Šálek T. Diagnostika diabetu mellitus 2. Typu Acta medicinae; 2012: 17-18

 

8. Šálek T. Současné metody stanovení glomerulární filtrace a jejich klinický význam. Kardiol rev 2010; 12: 151–152

 

9. Šálek T. Laboratorní diagnostika mnohočetného myelomu. Interní Med. 2008; 10: 407–409Šálek T. Laboratorní diagnostika diabetes mellitus a diabetické nefropatie. Med. Pro Praxi 2007; 4: 369–370

 

 

1. D) Učebnice a učební texty:

Švagera, Z., Kušnierová, P., Ploticová, V., Zeman, D., Šafarčík, K., Andelová, K., Šálek, T., Schneiderka, P. a Stejskal, D. Klinická biochemie pro bakalářské studijní obory 2. díl. 2023. ISBN: 978-80-7599-351-9

Porubän, T., Zulák, M., Ploticová, V., Šálek, T., Švagera, Z., Zeman, D. Vybrané kazuistiky z klinické biochemie. Ostrava: Ostravská univerzita, 2018. ISBN 978-80-7599-018-1.

Recenze studijního materiálu:

Kušnierová, P., Šigutová, R., Švagera, Z., Šafarčík, K., Bartoš, V., Zeman, D. a Ploticová, V. Klinická biochemie pro bakalářské studijní obory 1. díl. 2014.
Švagera, Z., Kušnierová, P., Šigutová, R., Ploticová, V., Zeman, D., Šafarčík, K. a Schneiderka, P. Klinická biochemie pro bakalářské studijní obory 2. díl. 2014.

1. E) RECENZE, Publikace z historie medicíny

Recenzoval jsem v těchto impaktovaných časopisech:
American journal of cardiovascular drugs
Clinical Chemistry and Laboratory Medicine,
Asia-Pacific journal of onkology,
Open medical case reports,
Metabolic syndrome and related disorders
Z českých časopisů jsem nejvíce recenzoval časopis Klinická biochemie a metabolismus
https://publons.com/researcher/1591542/tomas-salek/peer-review/

Publikace 50 let Mezioblastních seminářů Spolku lékařů (3. Autor)
https://www.kntb.cz/userfiles/50_let_csl.pdf

1. F) INVITED SPEAKER

Šálek T, 3rd World congress on Pharmacology and Toxicology. Lecture: Estimated glomerular filtration rate for drug dosing, September 12-14 2019, London, UK

Šálek T, přednáška Vyšetření funkce ledvin u onkologických pacientů.
45. Brněnské onkologické dny, Brno. 15. 10. 2021

1. K) Abstrakta ze sjezdů a sympozií

Viz příloha Přednášky a postery na konferencích.
Celkem 119 aktivních účastí, z toho 12 přednášek v zahraničí v angličtině a 6 posterů (z toho 4 postery v zahraničí). 26 prací vyšlo ve sbornících.

 

 

1. I) GRANTY, PROJEKTY

Projekt Leonardo da Vinci. MUDr. Šálek byl hlavní řešitel za Českou republiku.
CZ/13/LLP-LdV/PS/P/134024
Webové stránky projektu, kterého se úšastnili partneři z UK, Malty, Chorvatska, Maďarska a ČR. http://enhanceit.eu/doc

PROJEKT ROCO CZ.1.07/2.4.00/17.0016 Partnerství pro komplexní rozvoj kompetencí a vzdělávání v oblasti managementu ve zdravotnictví“(MUDr. Šálek byl Hlavní řešitel za Krajsou nemocnici T. Bati)

Projekty Pracovní skupiny Postanalytical phase EFLM – European Federation of Clinical Chemistry and Laboratory Medicine. Jsem jejím full member
EFLM :: European Federation of Clinical Chemistry and Laboratory Medicine

Časný záchyt Familiární hypercholesterolémie.
Registrační číslo projektu: CZ.03.2.63/0.0/0.0/15_039/0009642
Oddělení klinické biochemie a farmakologie provádí některé laboratorní testy a plánují se publikační výstupy

 

 

 

 

 

 

 

 

V Hradci Králové, 12. 7 2025                                          MUDr. Tomáš Šálek, PhD